IL2 and non-small cell lung carcinoma: Low concentration of IL-2 led to increased immune suppression by binding to Treg, while increased levels led to immune activation by binding/activating NK and CD8+ T cells and were correlated with improved OS and better response to PD-1/PD-L1 blockade in NSCLC.